Advanced search×

[Therapy of fundus oculi vascular pathology by solcoseryl].

E G EG Eliseeva, O K OK Vorob'eva, and N V NV Astaf'eva

Vestn Oftalmol 115(6):37-8 (1999) PMID 10665289

Long (for more than 17 years) therapy of 2331 patients (3122 eyes) with vascular conditions of the fundus oculi by a retinotropic drug solcoseryl showed its high efficacy as a monotherapy and in complex with other traditional and symptomatic treatments. Solcoseryl improved the visual function and hemodynamics of retinal vessels, promoted a more stable and longer stabilization of the treatment results, and accelerated the rehabilitation of patients.

Version: za2963e q8zaf q8zbd q8zce q8zda q8ze8 q8zf9 q8zgd
Buy PDF

Similar articles you may find interesting…

  1. Phonation after cervical spinal cord injury (CSCI): Prospective case examinations of the acute and sub-acute stages of recovery.
    Naomi Macbean, Elizabeth Ward, and Timothy Geraghty

    Int J Speech Lang Pathol 15(3):312-23 (2013) PMID 23642209

    Abstract The aim of the investigation was to examine the changes in phonation and related quality-of-life in the acute and sub-acute stages of recovery post-cervical spinal cord injury (CSCI). A prospective examination of phonation was conducted using perceptual and instrumental meas...
    Buy PDF
  2. Noninvasive Investigation of Deep Vascular Pathologies of Exudative Macular Diseases by High Penetration Optical Coherence Angiography.
    Young-Joo Hong, Masahiro Miura, and Yoshiaki Yasuno

    Invest Ophthalmol Vis Sci (2013) PMID 23633664

    HP-OCA revealed depth-resolved abnormal vasculatures in exudative macular diseases. The en face HP-OCA images showed high similarity with FA and ICGA images. These results suggest HP-OCA can be used for non-invasive and three-dimensional angiography in a clinical routine....
    Buy PDF
  3. Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease.
    Termpanit Chalermpalanupap, Becky Kinkead, and Allan I Levey

    Alzheimers Res Ther 5(2):21 (2013) PMID 23634965

    The Alzheimer's disease (AD) epidemic is a looming crisis, with an urgent need for new therapies to delay or prevent symptom onset and progression. There is growing awareness that clinical trials must target stage-appropriate pathophysiological mechanisms to effectively develop disea...
    PDF not found